Skip to main content

Aadi Gadekar - Student Research and Creativity Forum - Hofstra University

Page 1

Head and Neck Squamous Cell Carcinoma (HNSCC)-Derived Extracellular Vesicles (EVs) Contribute to Varied Chemokine Expression Profiles in M0 THP-1 Macrophages (MΦ) Aadi Gadekar1, Christopher J Papayannakos1, James A DeVoti1, Mohd Israr1, Fung Lam1, Bettie M Steinberg1, Vincent Bonagura1 1Institute of Molecular Medicine, The Feinstein Institutes for Medical Research at Northwell

BACKGROUND

• 900k new cases of HNSCC annually • Therapy-resistance growing issue •

RESULTS

1. Median EV Diameter Varied in HNSCC Cell Lines

Tumor-associated macrophages (TAMs) • Aid tumor growth • Shape tumor microenvironment (TME) with cytokines and chemokines

*** *

Extracellular Vesicles (EVs), like exosomes, are membrane-bound nanoparticles • Role in tumor-macrophage crosstalk

Significant differences in EV characteristics observed across HNSCC cell lines

Significant differences observed in EV secretion rate across HNSCC cell lines

CM derived from all HNSCC cell lines induced all markers • SCC25 & SCC154 showed highest induction • Mirrors findings from primary monocytes stimulated with CM

***

Cytokines influence immune responses, chemokines are chemotactic for immunocytes • IL-6 = inflammation + angiogenesis • CXCL5 = recruits neutrophils • CXCL10 = recruits T-cells •

2. EV Diameters Distributions Were Mostly Similar Across HNSCC Cell Lines

***

CONCLUSION

• n=6, *** p <0.001, *p<0.05.

3. EV Secretion Varied Across Cell Lines

Representative distribution from NTA measurements. ***p<0.001

4. SCC25 + SCC154, CM & EVs, Induce IL-6 •

** ***

HPV+ and HPV- EVs induced IL-6 and CXCL10 expression • Limited induction of CXCL5 Induction of CXCL10 by SCC25 EVs suggests MΦ mediated T-cell recruitment

***

Future Work

OBJECTIVES

1.

2.

Investigate the physical characteristics and EV secretion rate across HNSCC cell lines. Investigate M0 macrophage response to EVs from different HNSCC cell lines. METHODS

1. THP-1 cells differentiated into MΦ with 100 ng/mL of PMA.

n=6, ***p<0.001, **p<0.01.

5. Robust Induction by CM, Mild EV Induction

IL-6 upregulation observed by SCC25 and SCC154. IL-6 creates pro-tumor TME with angiogenesis and recruitment of myeloid-derived stem cells.

6. SCC25 CM & EVs Induce CXCL10

1.

Optimize PMA-differentiation of THP-1 cells

2.

Conduct visualization studies to verify EV uptake by MΦ

3.

Conduct experiments with in primary human monocytes and in vivo models Implications

1. EV-mediated MΦ expression of chemokines and cytokines contributes to immunosuppressive TME

2. Conditioned media (CM) by HNSCC cell lines for 48 hours.

2. New potential therapeutic window for boosting treatment efficacy

3. EVs isolated from CM with ultracentrifugation.

3. Warrants further study on HNSCC-derived exosomal cargo

4. EVs characterized by nanoparticle tracking analysis (NTA). 5. MΦ stimulated with 10 or 100 EVs per cell for 24 hours. 6. qPCR measured gene expression changes normalized to GAPDH.

EVs induced CXCL5 less than CM. CXCL5-mediated neutrophil invasion in the TME shown to have poorer outcomes.

EV-mediated CXCL10 upregulation is similar to the upregulation seen by CM. CXCL10-mediated T-cell recruitment boosts anti-tumor immunity.

About the Feinstein Institutes The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York. Home to 50 research labs, 2,500 clinical About Northwell Health research 4,000 researchers staff, Feinstein Institutes is raising standardover of Northwellstudies Health isand New York State’s largest and health carethe provider and private employer, withthe 22 hospitals, 550 outpatient facilities and nearly 15,000 affiliated Wescience, care for bioelectronic more than two medicine, million people medical innovation through its five institutes ofphysicians. behavioral cancer, annually in the New York area and thanks to philanthropic our communities. Our health innovations and metro outcomes, andbeyond, molecular medicine. We’re support makingfrom breakthroughs in genetics, 63,500 employees – 15,000+mental nurses and overautoimmunity, 4,000 employed and doctors, including members of Northwell Health oncology, brain research, health, bioelectronic medicine – a new field of Physicianthat Partners – are working to health care for the better. We’re making breakthroughs medicine at science has the potential tochange revolutionize medicine. For more information about howinwe’re the Feinstein Institute. We're training the next generation of medical professionals at the visionary Donald and producing knowledge to cure disease, visit feinstein.northwell.edu. Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu.


Turn static files into dynamic content formats.

Create a flipbook
Aadi Gadekar - Student Research and Creativity Forum - Hofstra University by Hofstra University - Issuu